Latest Updates
-
Gold Rate In India Crash By Rs 12,000 From Record: Will 24K, 22K, 18K Gold Prices Rise Or Fall In Christmas Week? Gold & Silver Prediction Here -
20th or 21st December? When Is the Winter Solstice In 2025 And How Is It Different From Meteorological Winter -
‘Clean Air Is a Right, Not a Luxury’: ZONAIR3D Unveils India Expansion Plans -
World Meditation Day 2025: Meditation Beyond The Mat, Simple Moments That Bring Inner Peace -
Sreenivasan Passes Away: Malayalam Cinema Mourns The Legendary Actor-Writer's Demise -
Malayalam Film Industry Loses A Defining Voice: Actor, Screenwriter And Director Sreenivasan Passes Away At 69 -
Happy Birthday Dheeraj Dhoopar: How A TV Set Friendship Turned Into Love With Wife Vinny Arora -
Top Skin and Hair Concerns in India in 2025: What the Data Reveals -
International Human Solidarity Day 2025: History, Significance, and Why It Matters -
Purported Video of Muslim Mob Lynching & Hanging Hindu Youth In Bangladesh Shocks Internet
Biological E Ltd To Get mRNA Technology From WHO To Produce Covid-19 Vaccines
City-based vaccine maker Biological E. Limited on Monday said the company was selected as a recipient of mRNA technology to produce COVID-19 vaccines from the World Health Organisation.

A press release from BE Limited said the WHO's Advisory Committee on Vaccine Product Development (ACPDV) selected the firm after examining a number of proposals from India, as a recipient of mRNA (ribonucleic acid) technology from the global health body's technology transfer hub.
Mahima Datla, Managing Director, BE Ltd said: "BE has been investing in mRNA technologies since last year. This new technology will definitely strengthen our resolve to develop and manufacture more vaccines in future. This partnership with WHO will enhance our ability to develop next-generation mRNA vaccines that could be more suitable globally and expand the reach of vaccines availability worldwide.''
WHO and their partners will work with the Indian government and Biological E to develop a roadmap and put in place the necessary training and support for the vaccine maker to start producing mRNA vaccines as soon as possible.
Primarily set up to address the COVID-19 emergency, the WHO mRNA technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities.
mRNA vaccines use a messenger RNA created in a laboratory to teach the human cells how to produce a protein that in turn initiates an immune response inside the body against a particular disease. The immune response will fight the actual virus as it gets into the body.
At present, India has no COVID-19 vaccine made on an mRNA platform.
Last month, the Centra had given approval for Biological E's Corbevax to be administered to the 12-14 years age group across the country.
Disclaimer: The information provided in this article is for general informational and educational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or a qualified healthcare provider with any questions you may have regarding a medical condition.



Click it and Unblock the Notifications











